fundraising >
Loading...
Loading investors...
16,701 investors
16,701 investors |
Geography | Checks | Stages | Lead | Investment thesis | Value add | Typical terms | Socials | Reply rate | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | Staenberg Ventures
VC firm |  USA | $25k to $1M | 1. Idea or Patent 2. Prototype+4 | We invest in a broad set of opportunities. My main criteria is can I add value?! Sorry, I don't do "over the transom"... |
|
| ||||
 | MD Start |  France UK | $2.7M to $5.4M | 3. Early Revenue 4. Scaling | We invest in medical technologies. | We build medical device startups with hands-on operational leadership, engineering and prototyping support, regulatory and IP expertise, and access to strategic healthcare partners and investors. | We typically invest €2M–€4M in seed-stage medical device startups through a venture studio model, usually taking a 30%–50% equity stake in exchange for capital, operational support, and company-building resources. We also reserve additional follow-on capital to support companies through later financing rounds. |
|
Send email
| ||
 | Portland Investmen... | USA | N/A | 4. Scaling | We invest through investment fund management, portfolio and asset management, and hedge... |
|
Send email
| ||||
 | PlumTree Partners | USA | N/A | 2. Prototype 3. Early Revenue | We invest in growth opportunities and technology-enabled business services. |
|
Send email
| ||||
 | Malpani Ventures
|  India | $100k to $300k | 2. Prototype 3. Early Revenue | We invest in early revenue/ traction India focused companies across software/ SAAS, education and... |
|
| ||||
Get Fin free for 1 year with OpenVCUse code "OpenVC". Conditions apply. |
|||||||||||
 | MARL Accelerator
|  Canada Mexico+3 | $50k to $50k | 2. Prototype 3. Early Revenue | We invest in founders working on solving B2B problems in the sector of Mobility, AR/VR, Robotics, Logistics, Cybersecurity,... | GTM Strategy, Fundraising, Product Strategy and Roadmap. | We invest $50,000 for 5% equity |
|
Fill form
| ||
 | La Fabrique by CA VC firm | France | N/A | 3. Early Revenue | We invest in the future of banking, specifically in financial and fintech... |
|
Send email
| ||||
 | Aken Capital | UK | N/A | 4. Scaling | We invest in capital markets, traditional income, and alternative income streams with high... |
|
Send email
| ||||
 | Westchester Angels | USA | $10k to $50k | 3. Early Revenue | We invest in finance. |
|
Send email
| ||||
 | OHA Osnabrück Hea... |  Germany | N/A | 2. Prototype 3. Early Revenue | We invest in the healthcare sector, supporting startups. |
|
Send email
| ||||
 | Birgo Capital | USA | min. $500 | 5. Growth | We invest in buyout-style multifamily residential real estate in undervalued Midwest markets, focusing on value-add... |
|
| ||||
 | Coyote Ventures
VC firm | USA | $100k to $250k | 2. Prototype 3. Early Revenue | We invest in companies innovating in women’s health and wellness, in partnership with FemTech... |
|
| ||||
 | Trinity Innovation... VC firm |  China USA | N/A | 4. Scaling 5. Growth | We invest in pharmaceutical innovation projects. |
|
Send email
| ||||
 | Trifecta Retail Ve... VC firm | USA | N/A | 3. Early Revenue | We invest in entrepreneurial teams developing innovative online retail... |
|
Send email
| ||||
 | Eucalyptus VC firm |  Philippines | N/A | 3. Early Revenue | We invest in digital health and healthcare companies. |
|
Send email
| ||||
 | Vesper Biotechnolo...
Other |  Brazil | N/A | 1. Idea or Patent 2. Prototype+2 | We invest in transformative and truly disruptive biotechnology projects, by providing access to capital, our national and... | We are a biotech holding company that offers a collaborative portfolio environment, fostering synergy among our companies. With years of experience in management and operations, we provide founders with strategic guidance, access to an extensive network of industry contacts, and the resources needed to accelerate growth. Our hands-on approach ensures tailored support to help navigate the unique challenges of the biotech sector. We primarily invest in early-stage ventures, often joining as co-founders and actively participating in the company's development. Our approach is highly customized—we work closely with scientists and entrepreneurs to structure investments based on the specific needs and potential of each startup. Today, our portfolio includes eight companies across agriculture and human health. Headquartered in Florianópolis, Santa Catarina, Brazil, we bring expertise in company management, covering financial strategy, regulatory pathways, and fundraising support. | Our deal terms are evaluated on a case-by-case basis. The investment amount is determined based on the specific needs of each project, ensuring alignment with its objectives and growth potential. |
|
Submit deck
| ||
 | UP Venture Capital VC firm |  Turkey | N/A | 3. Early Revenue | We invest in a broad spectrum of opportunities as a modern financial firm. |
|
Send email
| ||||
 | Bering Capital VC firm | USA | N/A | 5. Growth 3. Early Revenue | We invest in pharmaceuticals, medical devices, and healthcare. |
|
Send email
| ||||
 | Atlanticus VC firm | USA | N/A | 4. Scaling | We invest in finance and financial services. |
|
Send email
| ||||
 | Edgemore Capital VC firm | USA | N/A | 5. Growth | We invest in various sectors, also offering consulting services. |
|
Send email
| ||||